Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Werner Seeger

Showing results (641-650 of 704) with videos related to

Pageof 71
Sort By:
American Heart Journal|June 1, 2002
Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertensionDavid Langleben, Brian W Christman, Robyn J Barst, et al.
Cardiovascular Research|October 29, 2020
Genetic deletion of p66shc and/or cyclophilin D results in decreased pulmonary vascular toneMareike Gierhardt, Oleg Pak, Akylbek Sydykov, et al.
American Journal of Respiratory and Critical Care Medicine|December 23, 2016
Antihistone Properties of C1 Esterase Inhibitor Protect against Lung InjuryMalgorzata Wygrecka, Djuro Kosanovic, Lukasz Wujak, et al.
Science Translational Medicine|November 28, 2014
Changing the mindset in life sciences toward translation: a consensusGeorg N Duda, David W Grainger, Megan L Frisk, et al.
The European Respiratory Journal|October 26, 2023
Fibroblast growth factor 10 reverses cigarette smoke- and elastase-induced emphysema and pulmonary hypertension in miceStefan Hadzic, Cheng-Yu Wu, Marija Gredic, et al.
American Journal of Respiratory and Critical Care Medicine|May 23, 2023
CEACAM6 as a Novel Therapeutic Target to Boost HO-1-mediated Antioxidant Defense in COPDCheng-Yu Wu, Anis Cilic, Oleg Pak, et al.
JCI Insight|July 29, 2025
Living human lung slices for ex vivo modelling of lung cancerSiavash Mansouri, Annika Karger, Clemens Ruppert, et al.
Communications Biology|August 25, 2021
Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2Tatyana Novoyatleva, Nabham Rai, Baktybek Kojonazarov, et al.
Cell|October 18, 2011
Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in miceMichael Seimetz, Nirmal Parajuli, Alexandra Pichl, et al.
JMIR Public Health and Surveillance|July 20, 2018
Facial-Aging Mobile Apps for Smoking Prevention in Secondary Schools in Brazil: Appearance-Focused Interventional StudyBreno Bernardes-Souza, Francisco Patruz Ananias De Assis Pires, Gustavo Moreira Madeira, et al.
Pageof 71

Showing results (641-650 of 704) with videos related to

Sort By:
Pageof 71
American Heart Journal|June 1, 2002
Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertensionDavid Langleben, Brian W Christman, Robyn J Barst, et al.
Cardiovascular Research|October 29, 2020
Genetic deletion of p66shc and/or cyclophilin D results in decreased pulmonary vascular toneMareike Gierhardt, Oleg Pak, Akylbek Sydykov, et al.
American Journal of Respiratory and Critical Care Medicine|December 23, 2016
Antihistone Properties of C1 Esterase Inhibitor Protect against Lung InjuryMalgorzata Wygrecka, Djuro Kosanovic, Lukasz Wujak, et al.
Science Translational Medicine|November 28, 2014
Changing the mindset in life sciences toward translation: a consensusGeorg N Duda, David W Grainger, Megan L Frisk, et al.
The European Respiratory Journal|October 26, 2023
Fibroblast growth factor 10 reverses cigarette smoke- and elastase-induced emphysema and pulmonary hypertension in miceStefan Hadzic, Cheng-Yu Wu, Marija Gredic, et al.
American Journal of Respiratory and Critical Care Medicine|May 23, 2023
CEACAM6 as a Novel Therapeutic Target to Boost HO-1-mediated Antioxidant Defense in COPDCheng-Yu Wu, Anis Cilic, Oleg Pak, et al.
JCI Insight|July 29, 2025
Living human lung slices for ex vivo modelling of lung cancerSiavash Mansouri, Annika Karger, Clemens Ruppert, et al.
Communications Biology|August 25, 2021
Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2Tatyana Novoyatleva, Nabham Rai, Baktybek Kojonazarov, et al.
Cell|October 18, 2011
Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in miceMichael Seimetz, Nirmal Parajuli, Alexandra Pichl, et al.
JMIR Public Health and Surveillance|July 20, 2018
Facial-Aging Mobile Apps for Smoking Prevention in Secondary Schools in Brazil: Appearance-Focused Interventional StudyBreno Bernardes-Souza, Francisco Patruz Ananias De Assis Pires, Gustavo Moreira Madeira, et al.
Pageof 71